Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mölgaard

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Internal Medicine|May 1, 1990
Decreased mitogenic activity in hypercholesterolaemic plasmaJ Mölgaard, M Carlsson, J Nilsson, et al.
European Heart Journal|May 1, 1988
Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemiaJ Mölgaard, H von Schenck, A G Olsson
The American Journal of Cardiology|April 6, 1999
Efficacy and safety of simvastatin for high-risk hypercholesterolemiaJ Mölgaard, S Wärjerstam-Elf, A G Olsson
Atherosclerosis|May 1, 1987
Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemiaJ Mölgaard, H von Schenck, A G Olsson
Lancet (London, England)|August 16, 1986
Synvinolin in hypercholesterolaemiaA G Olsson, J Mölgaard, H von Schenk
Atherosclerosis|December 1, 1991
Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemiaJ Mölgaard, B L Lundh, H von Schenck, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Predilection of atherosclerosis for the inner curvature in the femoral artery. A digitized angiography studyO Smedby, J Johansson, J Mölgaard, et al.
Atherosclerosis|February 1, 1990
Effect of fish oil treatment on plasma lipoproteins in type III hyperlipoproteinaemiaJ Mölgaard, H von Schenck, C Lassvik, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|August 1, 1992
Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudicationJ Mölgaard, I C Klausen, C Lassvik, et al.
Journal of Internal Medicine|March 1, 1992
Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudicationJ Mölgaard, M R Malinow, C Lassvik, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Internal Medicine|May 1, 1990
Decreased mitogenic activity in hypercholesterolaemic plasmaJ Mölgaard, M Carlsson, J Nilsson, et al.
European Heart Journal|May 1, 1988
Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemiaJ Mölgaard, H von Schenck, A G Olsson
The American Journal of Cardiology|April 6, 1999
Efficacy and safety of simvastatin for high-risk hypercholesterolemiaJ Mölgaard, S Wärjerstam-Elf, A G Olsson
Atherosclerosis|May 1, 1987
Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemiaJ Mölgaard, H von Schenck, A G Olsson
Lancet (London, England)|August 16, 1986
Synvinolin in hypercholesterolaemiaA G Olsson, J Mölgaard, H von Schenk
Atherosclerosis|December 1, 1991
Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemiaJ Mölgaard, B L Lundh, H von Schenck, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Predilection of atherosclerosis for the inner curvature in the femoral artery. A digitized angiography studyO Smedby, J Johansson, J Mölgaard, et al.
Atherosclerosis|February 1, 1990
Effect of fish oil treatment on plasma lipoproteins in type III hyperlipoproteinaemiaJ Mölgaard, H von Schenck, C Lassvik, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|August 1, 1992
Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudicationJ Mölgaard, I C Klausen, C Lassvik, et al.
Journal of Internal Medicine|March 1, 1992
Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudicationJ Mölgaard, M R Malinow, C Lassvik, et al.
Pageof 3